PT Indofarma Tbk (ISX:INAF) EV-to-Revenue : 2.04 (As of May. 27, 2024)

View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, PT Indofarma Tbk's enterprise value is Rp1,394,712 Mil. PT Indofarma Tbk's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was Rp684,913 Mil. Therefore, PT Indofarma Tbk's EV-to-Revenue for today is 2.04.

The historical rank and industry rank for PT Indofarma Tbk's EV-to-Revenue or its related term are showing as below:

ISX:INAF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.29 Med: 2.63 Max: 16.06
Current: 2.03

During the past 13 years, the highest EV-to-Revenue of PT Indofarma Tbk was 16.06. The lowest was 0.29. And the median was 2.63.

ISX:INAF's EV-to-Revenue is ranked better than
54.64% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs ISX:INAF: 2.03

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), PT Indofarma Tbk's stock price is Rp280.00. PT Indofarma Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was Rp220.99. Therefore, PT Indofarma Tbk's PS Ratio for today is 1.27.

PT Indofarma Tbk EV-to-Revenue Historical Data

The historical data trend for PT Indofarma Tbk's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk EV-to-Revenue Chart

PT Indofarma Tbk Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

Get a 7-Day Free Trial

12.92

2.23

7.45

2.45

3.39

PT Indofarma Tbk Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EV-to-Revenue	Get a 7-Day Free Trial															1.44	3.39	2.66	2.59	2.99

Competitive Comparison of PT Indofarma Tbk's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Indofarma Tbk's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's EV-to-Revenue falls into.

PT Indofarma Tbk EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

PT Indofarma Tbk's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1394712.144	/	684912.942
	=	2.04

PT Indofarma Tbk's current Enterprise Value is Rp1,394,712 Mil.
PT Indofarma Tbk's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp684,913 Mil.

PT Indofarma Tbk (ISX:INAF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

PT Indofarma Tbk's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	280.00	/	220.992
	=	1.27

PT Indofarma Tbk's share price for today is Rp280.00.
PT Indofarma Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp220.99.

PT Indofarma Tbk EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Indofarma Tbk (ISX:INAF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530

Website

http://www.indofarma.id

PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines